A. Bockisch

2.2k total citations
98 papers, 1.5k citations indexed

About

A. Bockisch is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, A. Bockisch has authored 98 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Endocrinology, Diabetes and Metabolism, 44 papers in Radiology, Nuclear Medicine and Imaging and 19 papers in Epidemiology. Recurrent topics in A. Bockisch's work include Thyroid Cancer Diagnosis and Treatment (50 papers), Medical Imaging Techniques and Applications (21 papers) and Radiopharmaceutical Chemistry and Applications (19 papers). A. Bockisch is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (50 papers), Medical Imaging Techniques and Applications (21 papers) and Radiopharmaceutical Chemistry and Applications (19 papers). A. Bockisch collaborates with scholars based in Germany, United States and Netherlands. A. Bockisch's co-authors include Walter Jentzen, Rainer Görges, Lutz S. Freudenberg, Gerald Antoch, Klaus Mann, James Nagarajah, H.-J. Biersack, Onno E. Janßen, Maciej Bogdan Maniecki and Thomas Först and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A. Bockisch

95 papers receiving 1.5k citations

Peers

Countries citing papers authored by A. Bockisch

Since Specialization

Citations

This map shows the geographic impact of A. Bockisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bockisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bockisch more than expected).

Fields of papers citing papers by A. Bockisch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bockisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bockisch. The network helps show where A. Bockisch may publish in the future.

Co-authorship network of co-authors of A. Bockisch

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bockisch. A scholar is included among the top collaborators of A. Bockisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bockisch. A. Bockisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancer With MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study 2022 ·Nuklearmedizin - NuclearMedicine ·(unknown), (unknown), David Kersting, Christoph Rischpler, Walter Jentzen, Sarah Theurer, Tim Brandenburg, Ina Binse, Dagmar Führer‐Sakel, Hong Grafe, K. W. Schmid, Ken Herrmann, James Nagarajah, A. Bockisch	4
2	Initiale [18F]FDG-PET/CT bei Hochrisikopatienten mit differenziertem Schilddrüsenkarzinom 2016 ·Nuklearmedizin - NuclearMedicine ·Marcus Ruhlmann, Ina Binse, A. Bockisch, (unknown)	5
3	Diagnostik hyperfunktioneller Schilddrüsenknoten 2014 ·Nuklearmedizin - NuclearMedicine ·Marcus Ruhlmann, (unknown), Rainer Görges, (unknown), Dietmar Simon, A. Bockisch, (unknown), James Nagarajah	9
4	18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma 2013 ·Nuklearmedizin - NuclearMedicine ·Hinrich Wieder, Göknur Tekin, (unknown), Joachim Klode, Jens Altenbernd, A. Bockisch, James Nagarajah	20
5	124I-PET/CT-Bildgebung bei Patienten mit Schilddrüsenkarzinomen – Unterscheidung zwischen Schilddrüsenrest und Lymphknotenmetastasen durch kinetische Größen 2012 ·Nuklearmedizin - NuclearMedicine ·(unknown), James Nagarajah, Marcus Ruhlmann, A. Bockisch, Walter Jentzen	8
6	Estimation of tumour mass in patients with differentiated thyroid carcinoma using serum thyroglobulin 2012 ·Nuklearmedizin - NuclearMedicine ·Matthew J. Wieduwilt, James Nagarajah, A. Bockisch, Walter Jentzen, (unknown)	10
7	18F-Fluorid-PET/CT in der Skelettdiagnostik – Rolle der Schwächungskorrektur 2012 ·Nuklearmedizin - NuclearMedicine ·James Nagarajah, (unknown), Verena Hartung, A. Bockisch, (unknown)	5
8	Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodules 2012 ·Nuklearmedizin - NuclearMedicine ·(unknown), Rainer Görges, Florian Grabellus, A. Bockisch, (unknown), James Nagarajah	6
9	Pioglitazone therapy in progressive differentiated thyroid carcinoma 2012 ·Nuklearmedizin - NuclearMedicine ·A. Bockisch, James Nagarajah, (unknown)	13
10	Szintigraphisch mehranreichernde Schilddrüsenknoten gehen überwiegend mit normwertigem TSH einher 2011 ·Nuklearmedizin - NuclearMedicine ·(unknown), (unknown), Michael Zimny, R. Pink, H. Palmedo, (unknown), Heinrich Rau, (unknown), (unknown), A. Bockisch, Lutz Freudenberg, (unknown)	22
11	Vorbehalte der DGN zur Nutzenbewertung der PET durch das IQWiG 2010 ·Nuklearmedizin - NuclearMedicine ·J. Kotzerke, Markus Dietlein, F. Grünwald, A. Bockisch	7
12	Subjective perception of radioactivity 2009 ·Nuklearmedizin - NuclearMedicine ·(unknown), Thomas Beyer, A. Bockisch, Lutz S. Freudenberg	4
13	Chemotherapy with Doxorubicin in Progressive Medullary and Thyroid Carcinoma of the Follicular Epithelium 2008 ·Hormone and Metabolic Research ·(unknown), Stephan Petersenn, A. Bockisch, (unknown), Sien‐Yi Sheu, (unknown), Klaus Mann	59
14	Effekt verschiedener Chemoembolisationsmaterialien auf die CT-basierte Schwächungskorrektur der PET/CT 2007 ·RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Till A. Heusner, (unknown), Walter Jentzen, (unknown), Michael Forsting, A. Bockisch, Gerald Antoch	5
15	A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy. 2001 ·PubMed ·Daniel Kopf, (unknown), J. Beyer, (unknown), A. Bockisch, Hendrik Lehnert	7
16	Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer – a prospective,randomized, placebo-controlled, double-blind study 2001 ·British Journal of Oral and Maxillofacial Surgery ·K. A. Grötz, P W Wüstenberg, Ralf Kohnen, Bilal Al‐Nawas, Hans‐Heinrich Henneicke‐von Zepelin, A. Bockisch, J Kutzner, (unknown), G. G. Belz, Wilfried Wagner	42
17	Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma 1997 ·Clinical Endocrinology ·Daniel Kopf, A. Bockisch, Hans C. Steinert, Klaus M. Hahn, J. Beyer, H. P. H. Neumann, J. Hensen, Hendrik Lehnert	57
18	Peripheral Osteopenia in Adult Patients with Insulin‐dependent Diabetes Mellitus 1995 ·Diabetic Medicine ·Thomas Först, J. Beyer, A Pfützner, Peter Herbert Kann, (unknown), Ralf Lobmann, H. Schäfer, J. Andreas, A. Bockisch	80
19	HMPAO-SPECT unter Karotiskompression (Matas-Test) in der Diagnostik vor zervikalen Tumoreingriffen mit möglicher Karotisbeteiligung 1991 ·Laryngo-Rhino-Otologie ·(unknown), Frank Rosanowski, F. Grünwald, A. Bockisch, (unknown), H. J. Biersack, (unknown)	2
20	Qualitative und quantitative kernspintomographische Befunde der fokal nodulären Hyperplasie der Leber 1990 ·RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Burkhard Kreft, A. Steudel, (unknown), A. Bockisch, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact